The present invention relates to compounds able to inhibit the Monopolar Spindle 1 kinase (Mps-1 or TTK), according to the general formula (I), wherein R1, R2, R3, R4 , and R5 are as defined in the specification. The present application also relates to a process for their preparation, pharmaceutical compositions comprising them, and to their use as therapeutic agents, in particular for the treatment of cancer.
本发明涉及一种能够抑制单极纺锤体1激酶(Mps-1或
TTK)的化合物,其通式为(I),其中R1,R2,R3,R4和R5如规范中所定义。本申请还涉及它们的制备方法,包括它们的制剂,以及它们作为治疗剂的用途,特别是用于癌症的治疗。